Stay updated with breaking news from Rare Epilepsy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
One meta-analysis featuring 8 studies showed that more than half of patients reported a 100% reduction in their generalized tonic-clonic seizures or tonic-clonic seizures.
Share this article Share this article FALMOUTH, Maine, April 5, 2021 /PRNewswire/ -- The Foundation for USP7 Related Diseases (usp7.org) today announced a new research grant award to Neurolentech in a search for a cure to the rare disease Hao-Fountain Syndrome. The Austrian startup Neurolentech, led by Carsten Pfeffer, Ph.D. and co-founded by Gaia Novarino, Professor for Neuroscience at Institute of Science and Technology Austria (IST Austria), will receive $100,000 over two years towards funding studies that will focus on modeling Hao-Fountain Syndrome in cells. Group photo of Hao-Fountai...